JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Mizuho Financial
MFG
$126B
| $1.19M | ﹤0.01% |
274,384
+107,227
| +64% | +$430K |
|
3027
Liberty Broadband Class C
LBRDK
$4.79B
| $1.19M | ﹤0.01% |
23,264
-54,942
| -70% | -$2.93M |
|
3028
State Street SPDR S&P Global Dividend ETF
WDIV
$280M
| $1.18M | ﹤0.01% |
18,383
+1,526
| +9% | +$103K |
|
|
TMH
3029
DELISTED
Team Health Holdings Inc
TMH
| $1.18M | ﹤0.01% |
18,112
-30,909
| -63% | -$1.87M |
|
3030
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $1.18M | ﹤0.01% |
+23,683
| New | +$1.2M |
|
3031
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
| $1.18M | ﹤0.01% |
6,700
-21,300
| -76% | -$3.83M |
|
3032
PUT
Nu Skin
NUS
$254M
| $1.18M | ﹤0.01% |
+25,000
| New | +$1.35M |
|
3033
United Microelectronic
UMC
$47.5B
| $1.18M | ﹤0.01% |
574,154
+488,131
| +567% | +$1.1M |
|
3034
Harte-Hanks
HHS
$16.8M
| $1.18M | ﹤0.01% |
19,742
+140
| +0.7% | +$9.41K |
|
|
CFNL
3035
DELISTED
Cardinal Financial Corp
CFNL
| $1.17M | ﹤0.01% |
53,707
+302
| +0.6% | +$6.29K |
|
|
TNGO
3036
DELISTED
Tangoe, Inc.
TNGO
| $1.17M | ﹤0.01% |
92,905
-270
| -0.3% | -$3.63K |
|
3037
WisdomTree True Developed International Fund
DOL
$831M
| $1.17M | ﹤0.01% |
24,460
+1,952
| +9% | +$98.2K |
|
3038
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
| $1.17M | ﹤0.01% |
47,461
+3,560
| +8% | +$91.2K |
|
3039
Abercrombie & Fitch
ANF
$4.45B
| $1.16M | ﹤0.01% |
54,045
-521,617
| -91% | -$11.5M |
|
|
CVGW
3040
DELISTED
Calavo Growers
CVGW
| $1.16M | ﹤0.01% |
22,230
+134
| +0.6% | +$6.98K |
|
|
ALR
3041
DELISTED
AlerisLife Inc
ALR
| $1.16M | ﹤0.01% |
24,076
+9,750
| +68% | +$443K |
|
3042
New Oriental
EDU
$9B
| $1.15M | ﹤0.01% |
46,953
+36,947
| +369% | +$916K |
|
|
AVHI
3043
DELISTED
A V Homes, Inc.
AVHI
| $1.15M | ﹤0.01% |
80,000
| – | – |
|
|
JASO
3044
DELISTED
JA Solar Holdings, Co., Ltd
JASO
| $1.15M | ﹤0.01% |
134,378
+3,666
| +3% | +$34.7K |
|
3045
ENI
E
$80.5B
| $1.14M | ﹤0.01% |
32,154
+10,962
| +52% | +$404K |
|
|
SYT
3046
DELISTED
Syngenta Ag
SYT
| $1.14M | ﹤0.01% |
14,022
+4,033
| +40% | +$324K |
|
3047
First Trust Europe AlphaDEX Fund
FEP
$526M
| $1.14M | ﹤0.01% |
36,909
-19,156
| -34% | -$616K |
|
3048
Interparfums
IPAR
$4.02B
| $1.14M | ﹤0.01% |
33,644
+2,116
| +7% | +$70K |
|
|
GLOG
3049
DELISTED
GASLOG LTD
GLOG
| $1.14M | ﹤0.01% |
57,186
+41,502
| +265% | +$876K |
|
|
WX
3050
PUT
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $1.14M | ﹤0.01% |
+27,000
| New | +$1.14M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.